@import url(/styles/cuteeditorstylesheet.css);
AS PRINCIPLE INVESTIGATOR: 22
1. DBT-VINNOVA [INDO-SWEDEN]: 90.64 LAKHS [5 YEARS, 2010-2015]
2. DBT-SRC [INDO-SWEDEN]: 61.92 LAKHS [3 YEARS, 2014-2017]
3. DBT-VINNOVA [INDO-SWEDEN]: 67.00 LAKHS [3 YEARS, 2017-2020]
4. DBT-COE [BITS-IISC]: 39.56 LAKHS [5 YEARS, 2005-2010]
5. DBT-ICMR [BITS-NIRT]: 51.67 LAKHS [3 YEARS, 2012-2015]
6. DST-IBSA [INDIA-BRASIL-SOUTH AFRICA]: 31.84 LAKHS [3 YEARS, 2012-2015]
7. DST: 27.61 LAKHS [3 YEARS, 2014-2017]
8. DST: 23.80 LAKHS [3 YEARS, 2010-2013]
9. CSIR-OSDD [BITS-NII]: 31.70 LAKHS [1 YEAR, 2010]
10. CSIR-OSDD [BITS-NII-IIT KANPUR]: 38.64 LAKHS [3 YEAR, 2011-2014]
11. DST-[INDO-POLISH]: 11.89 LAKHS [2 YEARS, 2015-2017]
12. DBT-TATA INNOVATION: 45.00 LAKHS [5 YEARS, 2016-2021]
13. CSIR: 16.98 LAKHS [3 YEARS, 2005-2008]
14. ICMR: 23.03 LAKHS [3 YEARS, 2004-2007]
15. CSIR: 7.96 LAKHS [3 YEARS, 2010-2013]
16. UGC: 10.21 LAKHS [3 YEARS, 2005-2008]
17. UGC: 5.32 LAKHS [3 YEARS, 2009-2012]
18. AstraZeneca: 11.11 LAKHS [2010-2013]
19. Aditya Birla Group: 12.00 LAKHS [2011-2014]
20. Karolinska Institute: 18.00 LAKHS [2021-2023]
21. ISSAR Pharmaceuticals: 29.00 LAKHS [2020-2022]
Pravi Bio: 14.20 LAKHS [2022- ]
AS CO-INVESTIGATOR: 9
1. DBT INDO-BRAZIL project - ENZYMES FROM PURINE AND PYRIMIDINE BIO-SYNTHETIC PATHWAY AS TARGETS FOR THE DEVELOPMENT OF MYCOBACTERIUM TUBERCULOSIS DRUGS-2014-2017|
2. DST INDO-PORTUGAL project- DEVELOPMENT OF NOVEL COMPOUNDS FOR THE TREATMENT OF NEURAL COMPLICATIONS OF DIABETES-2014-2017|
3. ICMR-INSERM (Indo-France) project- STRUCTURE-BASED DESIGN OF ORPHAN NUCLEAR RECEPTOR MODULATOR TO TREAT DIABETES AND ITS COMPLICATIONS BY TARGETING RORALPHA AND REV-ERBALPHA-2014-2016|
4. DST INDO-UKRAINE JOINT PROJECT-DEVELOPMENT OF ANTIEPILEPTIC LEADS TO SUPPRESS HIPPOCAMPAL EPILEPTIC SEIZURES-2012-2015|
5. DST Major Research Project- DRUG DISCOVERY OF INHIBITORS OF THE PROTEASE OF PERIPHERAL MACROPHAGES AND MICROGLIAL CELLS IN THE SPINAL CORD FOR THE TREATMENT OF NEUROPATHIC PAIN- 2011-2015|
6. CSIR project- DESIGN AND SYNTHESIS OF PHARMACOPHORIC HYBRIDS AS POTENTIAL LEADS FOR THE TREATMENT OF NEUROPATHIC PAIN-2012-2015|
7. DBT Project- DISCOVERY OF NOVEL MODULATORS OF NAD(+) DEPENDENT PROTEIN DEACETYLASE SIRT1 FOR THE TREATMENT OF VARIOUS HUMAN DISORDERS -2011-2014|
8. DBT Neuroresearch Project- STRUCTURE-GUIDED DESIGN OF NOVEL NON-PEPTIDIC NONCOVALENT SELECTIVE INHIBITORS OF THE SPINAL MICROGLIAL CATHEPSIN S FOR THE TREATMENT OF NEUROPATHIC PAIN-2011-2013|
9. CSIR project - SYNTHESIS AND NEUROPHARMACOLOGY OF 4-AMINOBUTYRIC ACID ANALOGUES-2006-2009|